We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer’s Prevnar 13 Patent Claims Wiped Out by PTAB
Pfizer’s Prevnar 13 Patent Claims Wiped Out by PTAB
In a victory for Merck, the U.S. Patent Trial and Appeal Board (PTAB) invalidated one of Pfizer’s patents for the company’s best-selling drug, the pneumonia vaccine Prevnar 13.